Adrian R Parry-Jones
Overview
Explore the profile of Adrian R Parry-Jones including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alghamdi I, Brunton L, Ashton C, Jenkins D, Parry-Jones A
BMJ Open Qual
. 2025 Jan;
14(1.
PMID: 39753243
Introduction: Stroke is a leading cause of mortality and morbidity, demanding prompt and accurate identification. However, prehospital diagnosis is challenging, with up to 50% of suspected strokes having other diagnoses....
2.
Parry-Jones A, Krishnamurthi R, Ziai W, Shoamanesh A, Wu S, Martins S, et al.
Int J Stroke
. 2024 Dec;
20(2):145-150.
PMID: 39629687
Background: Intracerebral hemorrhage (ICH) is stroke caused by non-traumatic bleeding into the brain. Aim: This factsheet provides summary statistics for ICH from the 2021 Global of Burden of Diseases Study....
3.
Almubayyidh M, Parry-Jones A, Jenkins D
BMJ Neurol Open
. 2024 Nov;
6(2):e000878.
PMID: 39493673
Introduction: Distinguishing patients with intracerebral haemorrhage (ICH) from other suspected stroke cases in the prehospital setting is crucial for determining the appropriate level of care and minimising the onset-to-treatment time,...
4.
Jones O, Mohamed S, Hinz R, Paterson A, Sobowale O, Dickie B, et al.
J Cereb Blood Flow Metab
. 2024 Oct;
45(2):233-243.
PMID: 39360420
Neuroinflammation is a promising therapeutic target in intracerebral hemorrhage (ICH), characterized in the brain by microglial activation and blood-brain barrier (BBB) breakdown. In this study, 36 acute, spontaneous, supratentorial ICH...
5.
Sobowale O, Hostettler I, Wu T, Heal C, Wilson D, Shah D, et al.
Front Neurol
. 2024 Apr;
15:1359760.
PMID: 38645743
Background: The relationship between baseline perihematomal edema (PHE) and inflammation, and their impact on survival after intracerebral hemorrhage (ICH) are not well understood. Objective: Assess the association between baseline PHE,...
6.
Parry-Jones A, Jarhult S, Kreitzer N, Morotti A, Toni D, Seiffge D, et al.
Eur Stroke J
. 2023 Dec;
9(2):295-302.
PMID: 38149323
Purpose: Intracerebral haemorrhage (ICH) is the most devastating form of stroke and a major cause of disability. Clinical trials of individual therapies have failed to definitively establish a specific beneficial...
7.
8.
Salman R, Stephen J, Tierney J, Lewis S, Newby D, Parry-Jones A, et al.
Lancet Neurol
. 2023 Oct;
22(12):1140-1149.
PMID: 37839434
Background: The safety and efficacy of oral anticoagulation for prevention of major adverse cardiovascular events in people with atrial fibrillation and spontaneous intracranial haemorrhage are uncertain. We planned to estimate...
9.
Parry-Jones A, Stocking K, MacLeod M, Clarke B, Werring D, Muir K, et al.
Eur Stroke J
. 2023 Jul;
8(3):819-827.
PMID: 37452707
Purpose: Recombinant human interleukin-1 receptor antagonist (anakinra) is an anti-inflammatory with efficacy in animal models of stroke. We tested the effect of anakinra on perihaematomal oedema in acute intracerebral haemorrhage...
10.
Hammerbeck U, Rowland J, Heal C, Collins R, Smith G, Birleson E, et al.
J Stroke Cerebrovasc Dis
. 2023 Apr;
32(7):106890.
PMID: 37099928
Background: Very early rehabilitation after stroke appears to worsen outcome, particularly in intracerebral haemorrhage (ICH). Plausible mechanisms include increased mean blood pressure (BP) and BP variability. Aims: To test associations...